ProShare Advisors LLC - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 65 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$334,000
+32.0%
18,386
-0.4%
0.00%
+100.0%
Q2 2020$253,000
+29.1%
18,457
+35.0%
0.00%0.0%
Q1 2020$196,000
-47.5%
13,676
-37.9%
0.00%
-50.0%
Q4 2019$373,000
-8.8%
22,012
-17.2%
0.00%0.0%
Q3 2019$409,000
-38.8%
26,600
-6.7%
0.00%
-50.0%
Q2 2019$668,000
-25.8%
28,507
-10.3%
0.00%
-20.0%
Q1 2019$900,000
-5.6%
31,768
+0.5%
0.01%
-28.6%
Q4 2018$953,000
-25.5%
31,603
-13.5%
0.01%
-22.2%
Q3 2018$1,279,000
+43.2%
36,517
-3.0%
0.01%
+50.0%
Q2 2018$893,000
+6.6%
37,651
+15.1%
0.01%
+20.0%
Q1 2018$838,000
+26.8%
32,725
-14.1%
0.01%0.0%
Q4 2017$661,00038,0760.01%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Bellevue Group AG 3,204,244$45,821,0000.89%
Amia Capital LLP 21,337$305,0000.27%
Virtus ETF Advisers LLC 30,486$436,0000.18%
Motley Fool Asset Management LLC 59,972$858,0000.11%
Caption Management, LLC 81,600$1,168,0000.07%
Dynamic Technology Lab Private Ltd 16,826$241,0000.05%
Caption Management, LLC 57,000$816,0000.05%
ALPS ADVISORS INC 170,720$2,441,0000.04%
TUDOR INVESTMENT CORP ET AL 28,364$406,0000.04%
AIGEN INVESTMENT MANAGEMENT, LP 14,515$208,0000.03%
View complete list of AKCEA THERAPEUTICS INC shareholders